Longitudinal psychiatric symptoms in prodromal Huntington's disease: A decade of data

American Journal of Psychiatry

Volumn 173, Issue 2, 2016, Pages 187-192

  Epping, Eric A ^a   Kim, Ji In ^a   Craufurd, David ^a   Brashers Krug, Thomas M ^a   Anderson, Karen E ^a   McCusker, Elizabeth ^a   Luther, Jolene ^a   Long, Jeffrey D ^a   Paulsen, Jane S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ADULT; ANXIETY; ARTICLE; BRADYKINESIA; CHOREA; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; HOSTILITY; HUMAN; HUNTINGTIN GENE; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PATHOGENESIS; PHOBIA; PRIORITY JOURNAL; PROBABILITY; PRODROMAL SYMPTOM; PSYCHOSIS; RATING SCALE; RIGIDITY; SELF REPORT; SOMATIZATION; SYMPTOM CHECKLIST 90; CASE CONTROL STUDY; CLINICAL TRIAL; COMPULSION; HUMAN RELATION; MIDDLE AGED; MULTICENTER STUDY; OBSESSION; PROSPECTIVE STUDY; PROXY; PSYCHOLOGY; SOMATOFORM DISORDER; STATISTICAL MODEL;

ADULT; ANXIETY; CASE-CONTROL STUDIES; COMPULSIVE BEHAVIOR; DEPRESSION; DISEASE PROGRESSION; FEMALE; HOSTILITY; HUMANS; HUNTINGTON DISEASE; INTERPERSONAL RELATIONS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; PHOBIC DISORDERS; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; PROXY; PSYCHOTIC DISORDERS; SELF REPORT; SOMATOFORM DISORDERS;

EID: 84957640182     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.14121551     Document Type: Article

References (43)

1. Walker FO: Huntington's disease. Semin Neurol 2007; 27:143-150
2. Ross CA, Tabrizi SJ: Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10:83-98
3. Beglinger LJ,O'Rourke JJ,WangC, et al: Earliest functional declines in Huntington disease. Psychiatry Res 2010; 178:414-418
4. Duff K, Paulsen JS, Beglinger LJ, et al: Frontal behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 2010; 22:196-207
5. Paulsen JS: Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 2011; 11:474-483
6. Paulsen JS, Smith MM, Long JD, et al: Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 2013; 84:1233-1239
7. Craufurd D, Thompson JC, Snowden JS: Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:219-226
8. Paulsen JS, Zhao H, Stout JC, et al: Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001; 57: 658-662
9. Paulsen JS, Conybeare RA: Cognitive changes in Huntington's disease. Adv Neurol 2005; 96:209-225
10. van Duijn E, Kingma EM, van der Mast RC: Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007; 19:441-448
11. Julien CL, Thompson JC, Wild S, et al: Psychiatric disorders in preclinical Huntington's disease. J Neurol Neurosurg Psychiatry 2007; 78:939-943
12. Kingma EM, van Duijn E, Timman R, et al: Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen Hosp Psychiatry 2008; 30:155-161
13. Tabrizi SJ, Langbehn DR, Leavitt BR, et al: Biological and clinical manifestations of Huntington's disease in the longitudinal TRACKHD study: cross-sectional analysis of baseline data. Lancet Neurol 2009; 8:791-801
14. van Duijn E, Kingma EM, Timman R, et al: Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008; 69:1804-1810
15. van Duijn E, Reedeker N, Giltay EJ, et al: Correlates of apathy in Huntington's disease. J Neuropsychiatry Clin Neurosci 2010; 22: 287-294
16. Paulsen JS, Hayden M, Stout JC, et al: Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 2006; 63:883-890
17. Paulsen JS, Langbehn DR, Stout JC, et al: Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008; 79:874-880
18. Paulsen JS, Long JD, Johnson HJ, et al: Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decadeof thePREDICT-HDstudy. Front Aging Neurosci 2014; 6:78
19. Duff K, Paulsen JS, Beglinger LJ, et al: Psychiatric symptoms in Huntington's disease before diagnosis: the Predict-HD study. Biol Psychiatry 2007; 62:1341-1346
20. Beglinger LJ, Paulsen JS, Watson DB, et al: Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J Clin Psychiatry 2008; 69:1758-1765
21. Epping EA, Mills JA, Beglinger LJ, et al: Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. J Psychiatr Res 2013; 47: 1423-1431
22. McCusker EA, Gunn DG, Epping EA, et al: Unawareness ofmotor phenoconversion in Huntington disease. Neurology 2013; 81: 1141-1147
23. Killoran A, Biglan KM, Jankovic J, et al: Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology 2013; 80:2022-2027
24. Ha AD, Beck CA, Jankovic J: Intermediate CAG repeats in Huntington's disease: analysis of COHORT. TremorOtherHyperkinet Mov (N Y) 2012; 2:2
25. Zhang Y, Long JD, Mills JA, et al: Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 2011; 156B:751-763
26. Penney JB Jr, Vonsattel JP, MacDonald ME, et al: CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997; 41:689-692
27. Derogatis LR, Yevzeroff H, Wittelsberger B: Social class, psychological disorder, and the nature of the psychopathologic indicator. J Consult Clin Psychol 1975; 43:183-191
28. Verbeke G, Molenberghs G: Linear Mixed Models for Longitudinal Data. New York, Springer-Verlag, 2000
29. Burnham KP, Anderson DR: Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach, 2nd ed. New York, Springer, 2002
30. Roos RA: Huntington's disease: a clinical review. Orphanet J Rare Dis 2010; 5:40
31. Kirkwood SC, Siemers E, Viken R, et al: Longitudinal personality changes among presymptomatic Huntington disease gene carriers. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15:192-197
32. Tabrizi SJ, Scahill RI, Owen G, et al: Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013; 12:637-649
33. Paulsen JS, Duff K: Extending MCI beyond Alzheimer disease. Neurology 2009; 72:1116-1117
34. Duff K, Paulsen J, Mills J, et al: Mild cognitive impairment in prediagnosed Huntington disease. Neurology 2010; 75:500-507
35. Paulsen JS, Long JD: Onset of Huntington's disease: can it be purely cognitive? Mov Disord 2014; 29:1342-1350
36. Deckel AW,Morrison D: Evidence of a neurologically based denial of illness in patients with Huntington's disease. Arch Clin Neuropsychol 1996; 11:295-302
37. Chatterjee A, Anderson KE, Moskowitz CB, et al: A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. J Neuropsychiatry Clin Neurosci 2005; 17:378-383
38. Ho AK, Robbins AO, Barker RA: Huntington's disease patients have selective problems with insight. Mov Disord 2006; 21:385-389
39. Hoth KF, Paulsen JS, Moser DJ, et al: Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 2007; 29:365-376
40. Orfei MD, Robinson RG, Bria P, et al: Unawareness of illness in neuropsychiatric disorders: phenomenological certainty versus etiopathogenic vagueness. Neuroscientist 2008; 14:203-222
41. Flashman LA: Disorders of awareness in neuropsychiatric syndromes: an update. Curr Psychiatry Rep 2002; 4:346-353
42. Ecklund-Johnson E, Torres I: Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings. Neuropsychol Rev 2005; 15:147-166
43. Huntington Study Group PHAROS Investigators: At risk for Huntington disease: the PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled. ArchNeurol 2006; 63:991-996